About Lauren Boal, MD

Lauren Boal is an attending Hematologist/Oncologist at Massachusetts General Hospital for Children.  She grew up in Westport, CT and Charlotte, NC, and attended Princeton University in Princeton, NJ for college where she obtained a bachelor of arts in History with a minor in Latin American Studies.  She went on to obtain her medical degree from Boston University School of Medicine in Boston, MA.  She completed her pediatric residency at Children's National Medical Center in Washington, DC.  While in residency, she became interested in pediatric solid tumors and remained at Children's National Medical Center for fellowship at the Center for Cancer and Blood Disorders in Pediatric Hematology/Oncology.  While completing her fellowship, she also conducted research at the Pediatric Oncology Branch of the National Cancer Institute in the National Institutes of Health.  Her research focused on a phase I clinical trial using a novel agent in refractory and recurrent pediatric solid tumors.  Her clinical interests include caring for children with leukemia, lymphoma, solid tumors, and benign hematology conditions.

Clinical Interests:



Mass General for Children: Pediatric Hematology & Oncology
55 Fruit St.
Yawkey Center for Outpatient Care
Suite 8B
Boston, MA 02114
Phone: 617-726-2737

Medical Education

  • MD, Boston University
  • Residency, Children's National Medical Center
  • Fellowship, Children's National Medical Center

American Board Certifications

  • Pediatric Hematology-Oncology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


    • Hittson L, Pedati C, Hoffner W. Visual diagnosis: 8-year-old Male with a Skin Mass and Inguinal Lymphadenopathy. Clear Cell Sarcoma. Pediatr Rev 2015 Aug;36(8):e26-9.
    • Leonard A, Boal LH, Pary P, et al. Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn. Transfusion 2019;59(4):1183-1189.

Reviews: Comments and Ratings